News Briefs

Manufacturer prices for insulin in the United States were “considerably” — often five or 10 times — higher than those in other Organisation for Economic Co-operation and Development countries, according to a new report from researchers at RAND Corp. The average price per unit across all types of insulin in the United States was $98.70, the report said, while other countries would have paid a fraction of that for the same insulins. In addition, “the analysis suggests that U.S. insulin prices would still have been considerably higher — about four times higher — than those in other countries even when accounting for potential rebates,” researchers wrote. View the report at https://bit.ly/3izlH6k.

CVS Health Corp. is offering Whil — a “digital training platform” focused on workplace mindfulness, stress resilience, sleep, and mental and emotional wellbeing — to its PBM clients as part of its Points Solutions Management offerings for employers. “Employers and other plan sponsors are increasingly looking for innovative tools to help people manage their mental health, especially in light of the COVID-19 pandemic,” Sree Chaguturu, M.D., CVS Caremark’s chief medical officer, said in an Oct. 1 news release. “Whil’s commitment to clinical evaluation and research aligns with our focus on helping our clients include clinically effective digital point solutions as part of their benefits packages.” Visit https://bwnews.pr/3d8T8vB.

© 2021 MMIT

AIS Health Staff

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/09/Drug_Benefits_Life_Sciences.jpg
November 23

Will ‘Build Back Better’ Spell Disaster for Pharma Innovation?

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-health-plan-weekly-Wall-Street-Isnt-Sweating-Cignas-Third-Quarter-MLR-Miss.jpg
November 23

Big Three PBMs’ 3Q Results Make Up for Insurer Disappointments

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_442155384.jpg
November 23

SCAN Health Opts to Invest in Medication Adherence Tool

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today